Triad Life Sciences

Triad Life Sciences is a biotech company founded in 2017 and based in the United States. The company's slogan, "Engineered by Nature, Powered by Science," encapsulates its dedication to innovating tissue-based solutions for wound treatment and regenerative applications. Triad focuses on addressing problems with Extracellular Matrixes (ECMs) through its breakthrough material science platform. Its value proposition revolves around being innovative, reliable, and affordable. Triad's commitment to innovation is evident in its emphasis on maximizing ECM technology to develop best-in-class products and advance scientific breakthroughs for the future. Moreover, the company reduces or eliminates material variance through stringent material selection and proprietary processing technology, ensuring consistently reliable products. In terms of affordability, Triad collaborates with customers to develop pricing strategies that cater to the diverse needs of caregivers and patients, thereby increasing access to its solutions. Notably, the company recently secured a $25.00M Venture Round investment on August 31, 2021, with AgeChem and Regal Funds Management as the investors. This investment underscores confidence in Triad's pioneering approach to biotech and its potential to drive impactful advancements in wound treatment and regenerative medicine.